Detection of DNA modifications by the 32P-postlabelling assay

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 378, Issue 1-2, 1997, Pages 1-12

  Phillips, David H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Biomonitoring; Carcinogen; DNA adduct; Genotoxicity; Oxidative damage

Indexed keywords

ACRIDINE DERIVATIVE; ACRIDINE MUSTARD; ALIPHATIC COMPOUND; ANTIINFECTIVE AGENT; AROMATIC COMPOUND; CARCINOGEN; COAL TAR; CYPROTERONE ACETATE; CYTOTOXIC AGENT; DACARBAZINE; DIETHYLSTILBESTROL; DNA; HORMONE; NUCLEOTIDE; PHOSPHATE; PHOSPHORAMIDE MUSTARD; PHOSPHORUS 32; PLATINUM; PROCARBAZINE; TAMOXIFEN; TOBACCO SMOKE;

ANALYTIC METHOD; APURINIC SITE; ARTICLE; ASSAY; BIOLOGICAL MONITORING; DNA ADDUCT; DNA DAMAGE; DNA MODIFICATION; ENVIRONMENTAL EXPOSURE; GENOTOXICITY; HUMAN; ISOTOPE LABELING; METABOLIC ACTIVATION; NONHUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; STANDARD; STANDARDIZATION; TECHNIQUE; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOGENS; DEOXYRIBONUCLEASES; DNA; DNA ADDUCTS; DNA DAMAGE; HUMANS; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORUS RADIOISOTOPES; PHOSPHOTRANSFERASES;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA; NICOTIANA TABACUM;

EID: 0030747224     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00092-4     Document Type: Article

References (100)

1. 32P-Labeling test for DNA damage, Proc. Natl. Acad. Sci. USA 78 (1981) 6126-6129.
2. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts, Carcinogenesis 3 (1982) 1081-1092.
3. K. Randerath, E. Randerath, Postlabelling methods - an historical review, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Adducts, International Agency for Research on Cancer, Lyon, 1993, pp. 3-9.
4. D.H. Phillips, Modern methods of DNA adduct determination, in: C.S. Cooper, P.L. Grover (Eds.), Chemical Carcinogenesis and Mutagenesis I, Handbook of Experimental Pharmacology, vol. 94/1, Springer-Verlag, Berlin, 1990, pp. 503-546.
5. 32P-postlabelling assay, Carcinogenesis 13 (1992) 1053-1074.
6. P.T. Strickland, M.N. Routledge, A. Dipple, Methodologies for measuring carcinogen adducts in humans, Cancer Epidemiol. Biomarkers Prev. 2 (1993) 607-619.
7. 32P-Postlabelling methods for DNA adduct detection: overview and critical evaluation, Drug Metab. Rev. 26 (1994) 67-85.
8. 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5′-monophosphates, Carcinogenesis 10 (1989) 1231-1239.
9. 32P-postlabelling: tlc separation of 5′-deoxynucleoside monophosphates, in: B. Singer, H. Bartsch (Eds.), The Role of Cyclic Nucleic Acid Adducts in Carcinogenesis and Mutagenesis, IARC, Lyon, 1986, pp. 437-448.
10. 32P-postlabeling method, Carcinogenesis 10 (1989) 1567-1577.
11. 32P-Post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification, Carcinogenesis 15 (1994) 877-882.
12. 32P-Postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene, Carcinogenesis 6 (1985) 1117-1126.
13. 32P-postlabeling analysis of aromatic carcinogen: DNA adducts, Cancer Res. 45 (1985) 5656-5662.
14. 32P-postlabeling test for structurally diverse DNA adducts, Carcinogenesis 7 (1986) 1543-1551.
15. 32P-postlabeling analysis, Carcinogenesis 9 (1988) 1055-1060.
16. 2 atoms of guanine, Chem. Res. Toxicol. 7 (1994) 752-761.
17. D.H. Phillips, P.L. Carmichael, A. Hewer, K.J. Cole, I.R. Hardcastle, G.K. Poon, A. Keogh, A.J. Strain, Activation of tamoxifen and its metabolite α-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes, Carcinogenesis 17 (1996) 88-94.
18. 6-methylguanine in DNA from human tissues, Carcinogenesis 13 (1992) 469-475.
19. 32P-postlabelling, Carcinogenesis 16 (1995) 613-617.
20. W. Pfau, U. Brockstedt, T. Shirai, N. Ito, H. Marquardt, Pancreatic DNA adducts formed in vitro and in vivo by the food mutagens 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAαC), Mutation Res. (1997) this issue.
21. 1 mice fed a high ω-3 fatty acid diet, Mutation Res. (1997) this issue.
22. J.M. Arif, W.A. Smith, R.C. Gupta, Tissue distribution of DNA adducts in rats treated by intramammilary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene, Mutation Res. (1997) this issue.
23. A. Giles, A. Seidel, D.H. Phillips, Covalent DNA adducts formed in mouse epidermis by benzo[g]chrysene, Carcinogenesis 17 (1996) 1331-1336.
24. N.C. Hughes, D.H. Phillips, Covalent binding of dibenzpyrenes and benzo[a]pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin, Carcinogenesis 11 (1990) 1611-1619.
25. S.J. Culp, M.C. Poirier, F.A. Beland, Biphasic removal of DNA adducts in a repetitive DNA sequence after dietary administration of 2-acetylaminofluorene, Environ. Health Perspect. 99 (1993) 273-275.
26. M. Suh, F. Ariese, G.J. Small, R. Jankowiak, A. Hewer, D.H. Phillips, Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation, Carcinogenesis 16 (1995) 2561-2569.
27. A. Gladek, J.G. Liehr, Mechanism of genotoxicity of diethylstilbestrol in vivo, J. Biol. Chem. 264 (1989) 16847-16853.
28. X. Han, J.G. Liehr, Induction of covalent DNA adducts in rodents by tamoxifen, Cancer Res. 52 (1992) 1360-1363.
29. I.N.H. White, F. de Matteis, A. Davies, L.L. Smith, C. Crofton-Sleigh, S. Venitt, A. Hewer, D.H. Phillips, Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57B1/6 mice and in human MCL-5 cells, Carcinogenesis 13 (1992) 2197-2203.
30. 5-ethyl]-tamoxifen implicates α-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen, Carcinogenesis 15 (1994) 1487-1492.
31. D.H. Phillips, P.L. Carmichael, A. Hewer, K.J. Cole, G.K. Poon, α-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes, Cancer Res. 54 (1994) 5518-5522.
32. M.R. Osborne, A. Hewer, I.R. Hardcastle, P.L. Carmichael, D.H. Phillips, Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen, Cancer Res. 56 (1996) 71-77.
33. 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite, Carcinogenesis 15 (1994) 2087-2094.
34. D.N. Pathak, K. Pongracz, W.J. Bodell, Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen, Carcinogenesis 16 (1995) 11-15.
35. K. Pongracz, D.N. Pathak, T. Nakamura, A.L. Burlingame, W.J. Bodell, Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen, Cancer Res. 55 (1995) 3012-3015.
36. J. Topinka, U. Andrae, L.R. Schwarz, T. Wolff, Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures, Carcinogenesis 14 (1993) 423-427.
37. J. Topinka, B. Binkova, L.R. Schwarz, T. Wolff, Cyproterone acetate is an integral part of hepatic DNA adducts induced by this steroidal drug, Carcinogenesis 17 (1996) 167-169.
38. R.S. Kerdar, A. Baumann, M. Brudny-Klöppel, H. Biere, H. Blode, W. Kuhnz, Identification of 3α-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitro, Carcinogenesis 16 (1995) 1835-1841.
39. 32P-postlabelling of 7-methyl-dGMP and platinated dGpdG, Chem.-Biol. Interact. 74 (1990) 45-54.
40. 6 2′-deoxyguanosine 3′-monophosphate adducts of styrene oxide, Chem.-Biol. Interact. 77 (1991) 39-50.
41. P.D. Lawley, D.H. Phillips, DNA adducts from chemotherapeutic agents, Mutation Res. 355 (1996) 13-40.
42. A.E. Maccubbin, L. Caballes, G.B. Chheda, R.F. Struck, H.L. Gurtoo, Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine, Biochem. Biophys. Res. Commun. 163 (1990) 843-850.
43. 3 cells, Biochem. Pharmacol. 36 (1987) 4169-4171.
44. 32P-postlabelling to detect DNA adducts produced by experimental anticancer drugs: DNA-directed nitrogen mustards, Anti-Cancer Drug Design 9 (1994) 239-249.
45. 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines, Carcinogenesis 12 (1991) 1423-1431.
46. 32P-postlabelling, Nucleic Acids Res. 23 (1995) 1300-1306.
47. 32P-postlabelling assay for measurement of cisplatin-DNA intrastrand cross-links, Proc. Am. Assoc. Cancer Res. 37 (1996) 367.
48. N.C. Hughes, W. Pfau, A. Hewer, J. Jacob, G. Grimmer, D.H. Phillips, Covalent binding of polycyclic aromatic hydrocarbon components of coal tar to DNA in mouse skin, Carcinogenesis 14 (1993) 135-144.
49. B. Schoket, A. Hewer, P.L. Grover, D.H. Phillips, Covalent binding of components of coal-tar, creosote and bitumen to the DNA of the skin and lungs of mice following topical application, Carcinogenesis 9 (1988) 1253-1258.
50. P.L. Carmichael, A. Hewer, J. Jacob, G. Grimmer, D.H. Phillips, Comparison of total DNA adduct levels induced in mouse tissues and human skin by mainstream and sidestream cigarette smoke condensates, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Adducts, IARC, Lyon, 1993, pp. 321-326.
51. M.V. Reddy, G.R. Blackburn, C.A. Schreiner, C.R. Mackerer, Correlation of mutagenic potencies of various oils and oil coal tar mixtures with DNA adduct levels in vitro, Mutation Res. 378 (1997) 89-95.
52. D.H. Phillips, DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke, Environ. Health Perspect. 104 (Suppl. 3) (1996) 453-458.
53. K. Hemminki, E. Grzybowska, M. Chorazy, K. Twardowska-Saucha, J.W. Sroczynski, K.L. Putman, K. Randerath, D.H. Phillips, A. Hewer, R.M. Santella, T.L. Young, F.P. Perera, DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland, Carcinogenesis 11 (1990) 1229-1231.
54. E. Grzybowska, K. Hemminki, J. Szeliga, M. Chorazy, Seasonal variation of aromatic DNA adducts in human lymphocytes and granulocytes, Carcinogenesis 14 (1993) 2523-2526.
55. J. Lewtas, D. Walsh, R. Williams, L. Dobiás, Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for nonlinearity at high doses, Mutation Res. (1997) this issue.
56. 32P-Postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures, Mutation Res. (1997) this issue.
57. K. Hemminki, H. Rajaniemi, B. Lindahl, B. Moberger, Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients, Cancer Res. 56 (1996) 4374-4377.
58. P.L. Carmichael, A.H.N. Ugwumadu, P. Neven, A. Hewer, G.K. Poon, D.H. Phillips, Lack of genotoxicity of tamoxifen in human endometrium, Cancer Res. 56 (1996) 1475-1479.
59. 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls, Carcinogenesis 14 (1993) 1107-1110.
60. 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls, Carcinogenesis 12 (1991) 1727-1732.
61. 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients., Mutation Res. (1997) this issue.
62. 32P-postlabelling assay to aquatic biomonitoring, Mutation Res. (1997) this issue.
63. 32P-Postlabelling determination of DNA adducts in the earthworm Lumbricus terrestris exposed to PAH-contaminated soils, Bull. Environ. Contam. Toxicol. 54 (1995) 654-661.
64. 32P-postlabeling of thymine glycol in γ-irradiated DNA, Carcinogenesis 10 (1989) 43-47.
65. 32P-Postlabeling detection of thymine glycols: evaluation of adduct recoveries after enhancement with affinity chromatography, nuclease P1, nuclease S1, and polynucleotide kinase, Cancer Commun. 3 (1991) 109-117.
66. 32P-postlabeling detection of radiation-induced DNA damage: identification and estimation of thymine glycols and phosphoglycolate termini, Biochemistry 30 (1991) 1091-1097.
67. 32P-postlabeling assay for apurinic sites in DNA, Biochemistry 29 (1990) 1737-1743.
68. M. Weinfeld, M. Liuzzi, M.C. Paterson, Enzymatic analysis of isomeric trithymidylates containing ultraviolet light-induced cyclobutane pyrimidine dimers II. Phosphorylation by T4 polynucleotide kinase, J. Biol. Chem. 264 (1989) 6364-6370.
69. M. Weinfeld, J. Lee, G. Ruiqi, F. Karimi-Busheri, D. Chen, J. Allalunis-Turner, Use of a postlabelling assay to examine the removal of radiation-induced DNA lesions by purified enzymes and human cell extracts, Mutation Res. (1997) this issue.
70. 32P-Postlabelling approaches for the detection of 8-oxo-2′-deoxyguanosine-3′-monophosphate in DNA., Mutation Res. (1997) this issue.
71. R.J. Mauthe, V.M. Cook, S.L. Coffing, W.M. Baird, Exposure of mammalian cell cultures to benzo[a]pyrene and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation, Carcinogenesis 16 (1995) 133-137.
72. 1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA, Carcinogenesis 16 (1995) 419-422.
73. Q. Ye, W.J. Bodell, Production of 8-hydroxy-2′-deoxyguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen, Carcinogenesis 17 (1996) 1747-1750.
74. V.L. Wilson, B.G. Taffe, P.G. Shields, A.C. Povey, C.C. Harris, Detection and quantification of 8-hydroxydeoxyguanosine adducts in peripheral blood of people exposed to ionising radiation, Environ. Health Perspect. 99 (1993) 261-263.
75. 32P-postlabeling assay and the basal levels in rat tissues, Carcinogenesis 17 (1996) 917-924.
76. 32P-postlabeling in DNA modified by oxidative damage in vitro. Comparison with rat lung I-compounds, Mutation Res. 250 (1991) 135-144.
77. 32P-postlabelling of DNA adducts induced by a Fenton-type oxygen radical-generating system, Carcinogenesis 13 (1992) 1127-1135.
78. K. Randerath, E. Randerath, C.V. Smith, J. Chang, Structural origins of bulky oxidative DNA adducts (Type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence, Chem. Res. Toxicol. 9 (1996) 247-254.
79. 32P-postlabeling, Mutation Res. 291 (1993) 147-159.
80. E. Randerath, W.P. Watson, G.D. Zhou, J. Chang, K. Randerath, Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA), Mutation Res. 341 (1995) 265-279.
81. D.R. Lloyd, D.H. Phillips, P.L. Carmichael, Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack, Chem. Res. Toxicol., 10 (1997) in press.
82. H. Bartsch, A. Barbin, M.-J. Marion, J. Nair, Y. Guichard, Formation, detection, and role in carcinogenesis of ethenobases in DNA, Drug Metab. Rev. 26 (1994) 349-371.
83. M. Wang, K. Dhingra, W.N. Hittelman, J.G. Liehr, M. de Andrade, D. Li, Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues, Cancer Epidemiol. Biomarkers Prev. 5 (1996) 705-710.
84. 4-ethenodeoxycytidine, Mutagenesis 4 (1989) 75-77.
85. J.-L. Fang, C.E. Vaca, L.M. Valsta, M. Mutanen, Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition, Carcinogenesis 17 (1996) 1035-1040.
86. E. Randerath, G.-D. Zhou, K. Randerath, Organ-specific oxidative DNA damage associated with normal birth in rats, Carcinogenesis 17 (1996) 2563-2570.
87. K. Randerath, D. Li, B. Moorthy, E. Randerath, I-compounds - endogenous DNA markers of nutritional status, ageing, tumour promotion and carcinogenesis, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Adducts, International Agency for Research on Cancer, Lyon, 1993, pp. 157-165.
88. 32P-postlabelling assay, Carcinogenesis 10 (1989) 1557-1559.
89. 32P-Postlabelling of bile components: bulky adduct-like behaviour in polyethyleneimine-cellulose thin layer chromatography, Carcinogenesis 15 (1994) 2061-2064.
90. 32P-postlabelling to investigate DNA adduct formation by bile acids in vitro: lack of evidence for covalent binding, Carcinogenesis 16 (1995) 1489-1491.
91. K. Randerath, K.P. Gupta, K.L. van Golen, Altered fidelity of a nucleic acid modifying enzyme, T4 polynucleotide kinase, by safrole-induced DNA damage, Carcinogenesis 14 (1993) 1523-1529.
92. 32P-postlabelling assay, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Adducts, IARC, Lyon, 1993, pp. 211-214.
93. K. Hemminki, E. Grzybowska, M. Chorazy, K. Twardowska-Saucha, J.W. Sroczynski, K.L. Putman, K. Randerath, D.H. Phillips, A. Hewer, R.M. Santella, F.P. Perera, DNA adducts in humans related to occupational and environmental exposure to aromatic compounds, in: H. Vainio, M. Sorsa, A.J. McMichael (Eds.), Complex Mixtures and Cancer Risk, IARC, Lyon, 1990, pp. 181-192.
94. 32P-postlabelling assay for aromatic DNA adducts in white blood cells of iron foundry workers, Mutation Res. 224 (1989) 485-492.
95. 32P-postlabelling, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Damage, IARC, Lyon, 1993, pp. 35-49.
96. 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study, Mutation Res. (1997) this issue.
97. 32P-postlabeling and ELISA, Carcinogenesis 15 (1994) 557-560.
98. 32P-postlabelling and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation and peroxidation, Mutation Res. (1997) this issue.
99. 32P-postlabeled DNA adducts, Carcinogenesis 14 (1993) 1343-1348.
100. D.H. Phillips, P.B. Farmer, Protein and DNA adducts as biomarkers of exposure to environmental mutagens, in: D.H. Phillips, S. Venitt (Eds.), Environmental Mutagenesis, Bios, Oxford, 1995, pp. 367-395.